PubMed · 2017 · 11 citations · 19 references
MedicineCardiologyInternal MedicineCardiac TransplantationCardiovascular PharmacotherapyClinical CardiologyCardiac BiomarkersCardiac Risk AssessmentCardiovascular DiseaseHeart FailureHeart Failure PharmacotherapyB-type Natriuretic PeptidesCardiac Biomarker EvaluationChronic Heart Failure ManagementCongestive Heart Failure ManagementHeart Failure BiomarkersMultivariate Longitudinal Analysis
BACKGROUND: Circulating adiponectin concentration increases in patients with chronic heart failure (HF). We sought to explore the prognostic value of temporal changes in adiponectin concentration following treatment for chronic HF. METHODS: Serum adiponectin levels were measured at baseline and after a 3-month anti-failure treatment in 124 patients with symptomatic chronic systolic HF. Major adverse cardiac events (MACE) including death, heart transplantation, or hospitalization with worsening HF during a median follow-up period of 752 days were determined. RESULTS: Univariate and multivariate analysis showed that high levels of adiponectin after a 3-month treatment were associated with a 3.8-fold increased risk of MACE (p = 0.03), independent of amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels. Moreover, the combining of circulating levels of adiponectin with NT-proBNP provided independent and additional prognostic value in identifying high risk patients with MACE during follow-up. CONCLUSIONS: Changes in adiponectin and NT-proBNP over time provide prognostic information. When adiponectin is used in conjunction with NT-proBNP in chronic HF, the prognostic value may be better than if each biomarker is used separately.
19
Joachim Fruebis, Tsu‐Shuen Tsao, Sandrine Javorschi et al. · Proceedings of the National Academy of Sciences · 2001 · 1.9K citations · Full text
Adiponectin acts in the brain to decrease body weight
Yong Qi, Nobuhiko Takahashi, Stanley M. Hileman et al. · Nature Medicine · 2004 · 809 citations
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
Caroline Kistorp, Jens Faber, Søren Galatius et al. · Circulation · 2005 · 605 citations
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Coralie Sengenès, M Berlan, Isabelle de Glisezinski et al. · The FASEB Journal · 2000 · 492 citations